These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 22384092)

  • 1. In vivo fluorescence lifetime imaging monitors binding of specific probes to cancer biomarkers.
    Ardeshirpour Y; Chernomordik V; Zielinski R; Capala J; Griffiths G; Vasalatiy O; Smirnov AV; Knutson JR; Lyakhov I; Achilefu S; Gandjbakhche A; Hassan M
    PLoS One; 2012; 7(2):e31881. PubMed ID: 22384092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using in vivo fluorescence lifetime imaging to detect HER2-positive tumors.
    Ardeshirpour Y; Sackett DL; Knutson JR; Gandjbakhche AH
    EJNMMI Res; 2018 Apr; 8(1):26. PubMed ID: 29619584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo assessment of HER2 receptor density in HER2-positive tumors by near-infrared imaging, using repeated injections of the fluorescent probe.
    Ardeshirpour Y; Hassan M; Zielinski R; Horton J; Capala J; Gandjbakhche AH; Chernomordik V
    Technol Cancer Res Treat; 2014 Oct; 13(5):427-34. PubMed ID: 24000992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Affibody-DyLight conjugates for in vivo assessment of HER2 expression by near-infrared optical imaging.
    Zielinski R; Hassan M; Lyakhov I; Needle D; Chernomordik V; Garcia-Glaessner A; Ardeshirpour Y; Capala J; Gandjbakhche A
    PLoS One; 2012; 7(7):e41016. PubMed ID: 22911732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual-labeled trastuzumab-based imaging agent for the detection of human epidermal growth factor receptor 2 overexpression in breast cancer.
    Sampath L; Kwon S; Ke S; Wang W; Schiff R; Mawad ME; Sevick-Muraca EM
    J Nucl Med; 2007 Sep; 48(9):1501-10. PubMed ID: 17785729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Near-infrared quantum dots for HER2 localization and imaging of cancer cells.
    Rizvi SB; Rouhi S; Taniguchi S; Yang SY; Green M; Keshtgar M; Seifalian AM
    Int J Nanomedicine; 2014; 9():1323-37. PubMed ID: 24648731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of four affibody-based near-infrared fluorescent probes for optical imaging of epidermal growth factor receptor positive tumors.
    Qi S; Miao Z; Liu H; Xu Y; Feng Y; Cheng Z
    Bioconjug Chem; 2012 Jun; 23(6):1149-56. PubMed ID: 22621238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human breast cancer tumor models: molecular imaging of drug susceptibility and dosing during HER2/neu-targeted therapy.
    Gee MS; Upadhyay R; Bergquist H; Alencar H; Reynolds F; Maricevich M; Weissleder R; Josephson L; Mahmood U
    Radiology; 2008 Sep; 248(3):925-35. PubMed ID: 18647846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual-Labeled Near-Infrared/(99m)Tc Imaging Probes Using PAMAM-Coated Silica Nanoparticles for the Imaging of HER2-Expressing Cancer Cells.
    Yamaguchi H; Tsuchimochi M; Hayama K; Kawase T; Tsubokawa N
    Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27399687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative analysis of Her2 receptor expression in vivo by near-infrared optical imaging.
    Chernomordik V; Hassan M; Lee SB; Zielinski R; Gandjbakhche A; Capala J
    Mol Imaging; 2010 Aug; 9(4):192-200. PubMed ID: 20643022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo breast cancer characterization imaging using two monoclonal antibodies activatably labeled with near infrared fluorophores.
    Sano K; Mitsunaga M; Nakajima T; Choyke PL; Kobayashi H
    Breast Cancer Res; 2012; 14(2):R61. PubMed ID: 22510481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cy5.5-labeled Affibody molecule for near-infrared fluorescent optical imaging of epidermal growth factor receptor positive tumors.
    Miao Z; Ren G; Liu H; Jiang L; Cheng Z
    J Biomed Opt; 2010; 15(3):036007. PubMed ID: 20615009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination photoimmunotherapy with monoclonal antibodies recognizing different epitopes of human epidermal growth factor receptor 2: an assessment of phototherapeutic effect based on fluorescence molecular imaging.
    Ito K; Mitsunaga M; Nishimura T; Kobayashi H; Tajiri H
    Oncotarget; 2016 Mar; 7(12):14143-52. PubMed ID: 26909859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spectroscopically well-characterized RGD optical probe as a prerequisite for lifetime-gated tumor imaging.
    Mathejczyk JE; Pauli J; Dullin C; Napp J; Tietze LF; Kessler H; Resch-Genger U; Alves F
    Mol Imaging; 2011 Dec; 10(6):469-80. PubMed ID: 22201538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-sensitivity detection of breast tumors in vivo by use of a pH-sensitive near-infrared fluorescence probe.
    Mathejczyk JE; Pauli J; Dullin C; Resch-Genger U; Alves F; Napp J
    J Biomed Opt; 2012 Jul; 17(7):076028. PubMed ID: 22894511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fast clearing RGD-based near-infrared fluorescent probes for in vivo tumor diagnosis.
    Cao J; Wan S; Tian J; Li S; Deng D; Qian Z; Gu Y
    Contrast Media Mol Imaging; 2012; 7(4):390-402. PubMed ID: 22649045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo fluorescence lifetime imaging for monitoring the efficacy of the cancer treatment.
    Ardeshirpour Y; Chernomordik V; Hassan M; Zielinski R; Capala J; Gandjbakhche A
    Clin Cancer Res; 2014 Jul; 20(13):3531-9. PubMed ID: 24671949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Virus-resembling nano-structures for near infrared fluorescence imaging of ovarian cancer HER2 receptors.
    Guerrero YA; Bahmani B; Singh SP; Vullev VI; Kundra V; Anvari B
    Nanotechnology; 2015 Oct; 26(43):435102. PubMed ID: 26443474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spectral fluorescence molecular imaging of lung metastases targeting HER2/neu.
    Koyama Y; Hama Y; Urano Y; Nguyen DM; Choyke PL; Kobayashi H
    Clin Cancer Res; 2007 May; 13(10):2936-45. PubMed ID: 17504994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluorescence lifetime imaging of activatable target specific molecular probes.
    Alford R; Ogawa M; Hassan M; Gandjbakhche AH; Choyke PL; Kobayashi H
    Contrast Media Mol Imaging; 2010; 5(1):1-8. PubMed ID: 20101762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.